Treatment of Impetigo

Clinical Presentation and Etiology

• Impetigo is a highly contagious bacterial skin infection affecting the superficial layers of the epidermis, predominantly in children 2-5 years of age 1
• Causative organisms of nonbullous impetigo include Staphylococcus aureus and/or Streptococcus pyogenes, according to the Infectious Diseases Society of America 2, 3

Treatment Algorithm

First-Line Treatment: Topical Antibiotics

• The American Academy of Pediatrics and the Infectious Diseases Society of America recommend mupirocin 2% ointment applied to affected areas three times daily for 5-7 days for limited lesions 4
• Retapamulin 1% ointment is an alternative, applied twice daily for 5 days, as suggested by the Clinical Infectious Diseases guidelines 4

Second-Line Treatment: Oral Antibiotics

• The Infectious Diseases Society of America indicates that oral antibiotics, such as dicloxacillin or first-generation cephalosporins (e.g., cephalexin), are recommended for extensive disease, impractical topical therapy, failure of topical treatment, or systemic symptoms present 2, 4, 3
• The World Health Organization recommends completing the full course of prescribed antibiotics even if symptoms improve quickly, to ensure complete resolution of the infection 2

Special Considerations

Community-Acquired MRSA (CA-MRSA)

• The Centers for Disease Control and Prevention suggest considering empiric therapy for CA-MRSA in patients at risk for CA-MRSA infection, failure to respond to first-line therapy, or high local prevalence of CA-MRSA 2, 5
• The Infectious Diseases Society of America recommends treatment options for suspected CA-MRSA, including trimethoprim-sulfamethoxazole, clindamycin, or doxycycline 3

Treatment Duration and Follow-up

• The World Health Organization advises completing the full course of prescribed antibiotics, even if symptoms improve quickly, to prevent complications such as post-streptococcal glomerulonephritis 2, 4

Management of Impetigo in Adults

First-Line Treatment

• The Infectious Diseases Society of America recommends topical mupirocin 2% ointment applied three times daily for 5-7 days as the first-line treatment for adults with limited impetigo (up to 100 cm² total area) 6

Second-Line Treatment

• Oral antibiotics are indicated when impetigo is extensive, topical therapy is impractical, topical treatment has failed, or systemic symptoms are present, with dicloxacillin or cephalexin (first-generation cephalosporin) as the preferred oral agents for methicillin-susceptible S. aureus (MSSA) 6
• Amoxicillin-clavulanic acid is an acceptable alternative for MSSA 6
• For suspected or confirmed MRSA, recommended MRSA-active agents include trimethoprim-sulfamethoxazole, clindamycin 300-450 mg three times daily, and doxycycline 6

Evidence Quality Considerations

• The evidence demonstrates no significant difference in cure rates between topical and oral antibiotics for limited impetigo, supporting the preference for topical therapy to minimize systemic antibiotic exposure and resistance development 6
• The Infectious Diseases Society of America 2014 guidelines provide the framework for these recommendations, with recent guideline summaries reinforcing topical mupirocin as first-line for limited disease 6

Guidelines for Managing Impetigo in Young Children

Epidemiology & Clinical Presentation

• Impetigo is a highly contagious bacterial skin infection that resolves with appropriate antibiotic therapy, and children may resume normal activities once treatment starts and lesions begin to heal. 7
• The infection is caused by Staphylococcus aureus and/or Streptococcus pyogenes that colonize the skin surface and enter through minor cuts, insect bites, or scratches. 7, 8
• It most frequently affects children aged 2–5 years and spreads readily through direct skin contact or sharing of towels, clothing, and bedding. 7
• Typical lesions appear as honey‑colored crusts on the face and extremities or as fluid‑filled blisters that rupture, leaving a thin brown crust. 7

Preparation for Topical Therapy

• Before applying topical mupirocin, gently wash the affected area with soap and water. 9

Infection‑Control Measures (Hygiene)

• Keep the child’s fingernails trimmed short to reduce scratching and transmission. 9
• Encourage frequent hand‑washing with soap and water, especially after touching lesions. 9
• Do not share towels, washcloths, clothing, or bedding with other household members until the treatment course is finished. 9
• Wash all clothing, towels, and bedding in hot water daily during the first few days of therapy. 9

Activity & School Restrictions

• Keep the child home from school, daycare, and organized sports until at least 24 hours after initiating antibiotic treatment. 9
• Avoid participation in close‑contact sports and swimming pools until lesions are fully healed and no longer draining. 9

Warning Signs Requiring Prompt Evaluation

• Development or worsening of fever during treatment may indicate complications. 7
• Expansion of redness beyond the original lesions or increasing pain suggests disease progression. 7

Symptom Relief

• Soak lesions with warm, soapy water to soften crusts before applying medication, enhancing antibiotic penetration. 9
• Acetaminophen or ibuprofen may be used for discomfort, although impetigo is usually not painful. 10
• Maintain a cool environment for the child to help minimize itching. 9

Household Contact Management

• Examine siblings and close contacts for new lesions, as impetigo spreads easily within families. 9
• Prompt evaluation and treatment of any household members who develop lesions help prevent ongoing transmission. 9